GlassScriptPhysician profile
Antje Barreveld
NPI 1073789079
$64,431.45
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2021: $154 · 2022: $82.46 · 2023: $204 · 2024: $50K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $2,051 · Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,140.00 |
| Travel and Lodging | $2,051.08 |
| Food and Beverage | $1,021.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $62,640.36 | 2024-2025 | |
| Medtronic USA, INC. | $981.98 | 2019 | |
| Medtronic, INC. | $326.18 | 2021-2023 | Intellis Adaptivestim |
| Averitas Pharma INC. | $194.83 | 2023-2025 | Qutenza |
| Vertos Medical, INC. | $89.72 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.19 | 2024 | Relistor |
| Scilex Pharmaceuticals INC. | $34.00 | 2024 | |
| Nevro Corp. | $33.95 | 2024 | Senza |
| Pacira Pharmaceuticals Incorporated | $27.71 | 2024 | Exparel, Zilretta, Iovera |
| Baudax Bio INC. | $15.37 | 2022 | |
| Abbott Laboratories | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antje Barreveld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.